Skip to main content

Advertisement

Table 1 Patients characteristic

From: KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2

  Number of cases Age ± SD (range) Tumor grade [41] (WHO-UISP2011) Tumor stage [32] pTNM
Cases 70 64.21 ± 11.24 (29–91) G1 = 20 G2 = 26 G3 = 24 Stage 1 = 35Stage 2 = 16Stage 3 = 16Stage 4 = 1
Male 46 64.63 ± 11,84 (29–91) G1 = 15 G2 = 16 G3 = 15 Stage I = 23Stage II = 9Stage III =12Stage IV = 1
Female 24 63.42 ± 10.18 (45–79) G1 = 5 G2 = 10 G3 = 9 Stage I = 12Stage II = 7Stage III = 4Stage IV = 0